{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T21:52:48Z","timestamp":1770414768342,"version":"3.49.0"},"reference-count":12,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:p>\n            A patient received continuous infusion of cefazolin 10\u2009g then 8\u2009g daily for an external ventricular drainage-related methicillin-susceptible\n            <jats:named-content content-type=\"genus-species\">Staphylococcus aureus<\/jats:named-content>\n            (MSSA) ventriculitis. Median free concentrations in the cerebrospinal fluid were 11.9 and 6.1\u2009mg\/liter after 10- and 8-g doses, respectively.\n          <\/jats:p>","DOI":"10.1128\/aac.01844-18","type":"journal-article","created":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T11:35:34Z","timestamp":1541763334000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":23,"title":["High-Dosage Cefazolin Achieves Sufficient Cerebrospinal Diffusion To Treat an External Ventricular Drainage-Related\n            <i>Staphylococcus aureus<\/i>\n            Ventriculitis"],"prefix":"10.1128","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1232-5761","authenticated-orcid":false,"given":"Matthieu","family":"Gr\u00e9goire","sequence":"first","affiliation":[{"name":"Clinical Pharmacology Department, CHU Nantes, Nantes, France"},{"name":"UMR Inserm 1235 The Enteric Nervous System in Gut and Brain Disorders, University of Nantes, Nantes, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Gaborit","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, CHU Nantes and CIC 1413, Inserm, Nantes, France"},{"name":"EA 3826 Th\u00e9rapeutiques Cliniques et Exp\u00e9rimentales des Infections, University of Nantes, Nantes, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Deschanvres","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, CHU Nantes and CIC 1413, Inserm, Nantes, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rapha\u00ebl","family":"Lecomte","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, CHU Nantes and CIC 1413, Inserm, Nantes, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Deslandes","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Department, CHU Nantes, Nantes, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9ric","family":"Dailly","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Department, CHU Nantes, Nantes, France"},{"name":"EE1701 Microbiotas, Hosts, Antibiotics and Bacterial Resistances, University of Nantes, Nantes, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Ambrosi","sequence":"additional","affiliation":[{"name":"R\u00e9animation Chirurgicale Polyvalente, Service d\u2019Anesth\u00e9sie-R\u00e9animation, H\u00f4pital La\u00ebnnec, CHU Nantes, Nantes, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronan","family":"Bellouard","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Department, CHU Nantes, Nantes, France"},{"name":"EE1701 Microbiotas, Hosts, Antibiotics and Bacterial Resistances, University of Nantes, Nantes, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Asseray","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, CHU Nantes and CIC 1413, Inserm, Nantes, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Lakhal","sequence":"additional","affiliation":[{"name":"R\u00e9animation Chirurgicale Polyvalente, Service d\u2019Anesth\u00e9sie-R\u00e9animation, H\u00f4pital La\u00ebnnec, CHU Nantes, Nantes, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Boutoille","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, CHU Nantes and CIC 1413, Inserm, Nantes, France"},{"name":"EA 3826 Th\u00e9rapeutiques Cliniques et Exp\u00e9rimentales des Infections, University of Nantes, Nantes, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix287"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00243-16"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-004-0416-z"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-008-0059-8"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-8206.1996.tb00311.x"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx427"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2016.03.010"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00007-10"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-017-0588-3"},{"key":"e_1_3_2_11_2","first-page":"1496","article-title":"Effect of multidose therapy on cerebrospinal fluid penetration of cefazolin","volume":"38","author":"Moore TD","year":"1981","unstructured":"Moore TD, Bechtel TP, Ayers LW. 1981. Effect of multidose therapy on cerebrospinal fluid penetration of cefazolin. Am J Hosp Pharm 38:1496\u20131499.","journal-title":"Am J Hosp Pharm"},{"key":"e_1_3_2_12_2","first-page":"271","article-title":"Seizures associated with high cerebrospinal fluid concentrations of cefazolin","volume":"37","author":"Bechtel TP","year":"1980","unstructured":"Bechtel TP, Slaughter RL, Moore TD. 1980. Seizures associated with high cerebrospinal fluid concentrations of cefazolin. Am J Hosp Pharm 37:271\u2013273.","journal-title":"Am J Hosp Pharm"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2017.10.021"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01844-18","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01844-18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T21:34:35Z","timestamp":1645479275000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01844-18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.1128\/AAC.01844-18"],"URL":"https:\/\/doi.org\/10.1128\/aac.01844-18","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"2018-08-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01844-18"}}